Research Alliance Corp III
RACC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002118032
No open-market purchases or sales by Research Alliance Corp III insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $79.6M in total; no superinvestor holds it.
Holders of 5% or more of RACC
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Research Alliance Corp III, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Research Alliance Holdings III LLC /Cayman | 13D/A | 16.90%1.52M shares | +2.20 ppfrom 14.70% | May 29, 20262 filings | Jul 28, 2026 | SEC |
| ADAR1 Capital Management, LLC | 13G | 8.40%650.0K shares | New | Aug 14, 20261 filing | Aug 14, 2026 | SEC |
| Perceptive Advisors LLC | 13G | 8.20%750.0K shares | New | May 28, 20261 filing | May 28, 2026 | SEC |
| Bank of America Corp | 13G | 6.50%503.9K shares | New | Aug 3, 20261 filing | Aug 3, 2026 | SEC |
| Great Point Partners LLC | 13G | 6.49%504.9K shares | New | Sep 11, 20261 filing | Sep 11, 2026 | SEC |
| Balyasny Asset Management LLC | 13G | 6.43%500.0K shares | New | Aug 14, 20261 filing | Aug 14, 2026 | SEC |
| TCG Crossover GP III, LLC | 13G | 6.40%500.0K shares | New | Aug 14, 20261 filing | Aug 14, 2026 | SEC |
| Spruce Street Capital LP | 13G | 6.40%500.0K shares | New | Aug 13, 20261 filing | Aug 13, 2026 | SEC |
| Biotechnology Value Fund L P | 13G | 6.40%500.0K shares | New | May 29, 20261 filing | May 29, 2026 | SEC |
| Trails Edge Capital Partners, LP | 13G | 5.50%500.0K shares | New | May 29, 20261 filing | May 29, 2026 | SEC |
| Commodore Capital LP | 13G | 5.50%500.0K shares | New | May 28, 20261 filing | May 28, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
12 Schedule 13D and 13G filings on Research Alliance Corp III, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Sep 11, 20264:00 PM ET | Great Point Partners LLCand 2 others | 13G | 6.49%504.9K shares | New | Sep 4, 2026 | SEC |
| Aug 14, 20269:31 PM ET | ADAR1 Capital Management, LLCand 1 other | 13G | 8.40%650.0K shares | New | Jun 30, 2026 | SEC |
| Aug 14, 20264:16 PM ET | TCG Crossover GP III, LLCand 2 others | 13G | 6.40%500.0K shares | New | Jun 30, 2026 | SEC |
| Aug 14, 20266:07 AM ET | Balyasny Asset Management LLCand 4 others | 13G | 6.43%500.0K shares | New | Jun 30, 2026 | SEC |
| Aug 13, 20268:30 AM ET | Spruce Street Capital LPand 2 others | 13G | 6.40%500.0K shares | New | Jun 30, 2026 | SEC |
| Aug 3, 20264:25 PM ET | Bank of America Corp | 13G | 6.50%503.9K shares | New | Jun 30, 2026 | SEC |
| Jul 28, 20264:15 PM ET | Research Alliance Holdings III LLC /Caymanand 1 other | 13D/A | 16.90%1.52M shares | +2.20 ppfrom 14.70% | Jul 26, 2026 | SEC |
| May 29, 20265:51 PM ET | Biotechnology Value Fund L Pand 9 others | 13G | 6.40%500.0K shares | New | May 21, 2026 | SEC |
| May 29, 20265:28 PM ET | Research Alliance Holdings III LLC /Caymanand 1 other | 13D | 14.70%1.52M shares | New | May 21, 2026 | SEC |
| May 29, 20264:15 PM ET | Trails Edge Capital Partners, LPand 2 others | 13G | 5.50%500.0K shares | New | May 21, 2026 | SEC |
| May 28, 20264:20 PM ET | Commodore Capital LPand 3 others | 13G | 5.50%500.0K shares | New | May 20, 2026 | SEC |
| May 28, 20264:00 PM ET | Perceptive Advisors LLCand 2 others | 13G | 8.20%750.0K shares | New | May 20, 2026 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Research Alliance Corp III shares.
No Form 144 notices for Research Alliance Corp III are on file.